Associations of body mass index and waist circumference with incidence of overall and of 27 site‐specific cancers: a population‐based retrospective cohort study
Cancer Communications · 2025
DOI: 10.1002/cac2.70039 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Communications, 2025. Verfasst von Seonghye Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Healthcare Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Body Mass Index, Neoplasms, Waist Circumference, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korean Foundation for Cancer Research.
Abstract (Originalsprache)
Background
Overweight and obesity are known risk factors for cancer. The aim of this study was to investigate associations of body mass index (BMI) and waist circumference (WC) with incidence of 27 site‐specific cancers stratified by sex and menopausal status accounting for non‐linearity.
Methods
We performed a population‐based retrospective cohort study using the Korean National Health Insurance Service (KNHIS 2009‐2020) database. We included 3,986,155 participants (aged ≥ 20 years), and the mean follow‐up duration was 9.0 ± 1.6 years. The primary outcome was the incidence of cancer.
Results
There were positive associations between BMI or WC and incidences of cancers including overall cancer, digestive tract cancer (except for esophageal cancer), hepato‐bilio‐pancreatic cancer, hematological cancer, sex‐specific cancers, brain/central nervous system (postmenopausal women), thyroid, renal, and bladder cancers. We observed inverse associations for several cancers, including lung and laryngeal cancers.
Conclusions
Our findings of differential associations of BMI and WC with incidence of various cancers contribute to the understanding of the relationship between obesity and cancer risk in Asian populations. These results may provide evidence to support the implementation of active surveillance and targeted management strategies for obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Healthcare Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
- Korea Central Cancer Registry, National Cancer Center, Goyang, Republic of Korea.
- Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
- Department of Family Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
- Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Dong Wook Shin
Förderung
- Korean Foundation for Cancer Research
Zitieren
APA
Kim, S., Kim, B., Jung, K. W., Nam, G. E., Jung, W., Park, J., Han, K. D., & Shin, D. W. (2025). Associations of body mass index and waist circumference with incidence of overall and of 27 site‐specific cancers: a population‐based retrospective cohort study. Cancer Communications. https://doi.org/10.1002/cac2.70039
Vancouver
Kim S, Kim B, Jung KW, Nam GE, Jung W, Park J, et al. Associations of body mass index and waist circumference with incidence of overall and of 27 site‐specific cancers: a population‐based retrospective cohort study. Cancer Communications. 2025. doi:10.1002/cac2.70039
BibTeX
@article{Kim2025,
author = {Kim, Seonghye and Kim, Bongseong and Jung, Kyu-Won and Nam, Ga Eun and Jung, Wonyoung and Park, Junhee and Han, Kyung-Do and Shin, Dong Wook},
title = {Associations of body mass index and waist circumference with incidence of overall and of 27 site‐specific cancers: a population‐based retrospective cohort study},
journal = {Cancer Communications},
year = {2025},
doi = {10.1002/cac2.70039}
}
EUVIMED